{
 "url": "https://etfiq.com/funds/pjp/holdings/",
 "section": "funds",
 "title": "PJP Holdings: All 31 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 31 PJP holdings with weights, as of Oct 13, 2026. The top 3 are ABBV 5.92%, GILD 5.70% and PFE 5.69%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "PJP",
 "fund": "Invesco Pharmaceuticals ETF",
 "fund_page": "https://etfiq.com/funds/pjp",
 "positions": 31,
 "positions_listed_on_page": 31,
 "lead": "PJP held 31 positions as of Oct 13, 2026. AbbVie Inc is the largest at 5.92%; the top 10 are 50.6% of the fund.",
 "source": {
  "name": "Invesco",
  "url": "https://dng-api.invesco.com/cache/v1/accounts/en_US/shareclasses/46137V662/holdings/fund?idType=cusip&productType=ETF",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "AbbVie Inc",
   "ticker": "ABBV",
   "weight_pct": 5.915,
   "page": "https://etfiq.com/holdings/abbv/"
  },
  {
   "rank": 2,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 5.697,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 3,
   "holding": "Pfizer Inc",
   "ticker": "PFE",
   "weight_pct": 5.69,
   "page": "https://etfiq.com/holdings/pfe/"
  },
  {
   "rank": 4,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 5.417,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 5,
   "holding": "Amgen Inc",
   "ticker": "AMGN",
   "weight_pct": 5.337,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 6,
   "holding": "Johnson & Johnson",
   "ticker": "JNJ",
   "weight_pct": 5.216,
   "page": "https://etfiq.com/holdings/jnj/"
  },
  {
   "rank": 7,
   "holding": "Merck & Co Inc",
   "ticker": "MRK",
   "weight_pct": 5.2,
   "page": "https://etfiq.com/holdings/mrk/"
  },
  {
   "rank": 8,
   "holding": "Abbott Laboratories",
   "ticker": "ABT",
   "weight_pct": 5.056,
   "page": "https://etfiq.com/holdings/abt/"
  },
  {
   "rank": 9,
   "holding": "Amneal Pharmaceuticals Inc",
   "ticker": "AMRX",
   "weight_pct": 3.567,
   "page": "https://etfiq.com/holdings/amrx/"
  },
  {
   "rank": 10,
   "holding": "Ligand Pharmaceuticals Inc",
   "ticker": "LGND",
   "weight_pct": 3.519,
   "page": "https://etfiq.com/holdings/lgnd/"
  },
  {
   "rank": 11,
   "holding": "Perrigo Co PLC",
   "ticker": "PRGO",
   "weight_pct": 3.467,
   "page": "https://etfiq.com/holdings/prgo/"
  },
  {
   "rank": 12,
   "holding": "United Therapeutics Corp",
   "ticker": "UTHR",
   "weight_pct": 3.423,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 13,
   "holding": "Biogen Inc",
   "ticker": "BIIB",
   "weight_pct": 3.387,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 14,
   "holding": "Viatris Inc",
   "ticker": "VTRS",
   "weight_pct": 3.37,
   "page": "https://etfiq.com/holdings/vtrs/"
  },
  {
   "rank": 15,
   "holding": "Tarsus Pharmaceuticals Inc",
   "ticker": "TARS",
   "weight_pct": 3.238,
   "page": "https://etfiq.com/holdings/tars/"
  },
  {
   "rank": 16,
   "holding": "Innoviva Inc",
   "ticker": "INVA",
   "weight_pct": 3.2,
   "page": "https://etfiq.com/holdings/inva/"
  },
  {
   "rank": 17,
   "holding": "Corcept Therapeutics Inc",
   "ticker": "CORT",
   "weight_pct": 3.114,
   "page": "https://etfiq.com/holdings/cort/"
  },
  {
   "rank": 18,
   "holding": "Harmony Biosciences Holdings Inc",
   "ticker": "HRMY",
   "weight_pct": 3.105,
   "page": "https://etfiq.com/holdings/hrmy/"
  },
  {
   "rank": 19,
   "holding": "Prestige Consumer Healthcare Inc",
   "ticker": "PBH",
   "weight_pct": 3.079,
   "page": "https://etfiq.com/holdings/pbh/"
  },
  {
   "rank": 20,
   "holding": "ANI Pharmaceuticals Inc",
   "ticker": "ANIP",
   "weight_pct": 3.059,
   "page": "https://etfiq.com/holdings/anip/"
  },
  {
   "rank": 21,
   "holding": "Regeneron Pharmaceuticals Inc",
   "ticker": "REGN",
   "weight_pct": 2.951,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 22,
   "holding": "Bristol-Myers Squibb Co",
   "ticker": "BMY",
   "weight_pct": 2.756,
   "page": "https://etfiq.com/holdings/bmy/"
  },
  {
   "rank": 23,
   "holding": "Jazz Pharmaceuticals PLC",
   "ticker": "JAZZ",
   "weight_pct": 2.641,
   "page": "https://etfiq.com/holdings/jazz/"
  },
  {
   "rank": 24,
   "holding": "Collegium Pharmaceutical Inc",
   "ticker": "COLL",
   "weight_pct": 2.56,
   "page": "https://etfiq.com/holdings/coll/"
  },
  {
   "rank": 25,
   "holding": "Travere Therapeutics Inc",
   "ticker": "TVTX",
   "weight_pct": 2.525,
   "page": "https://etfiq.com/holdings/tvtx/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": -0.001
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/pjp/holdings/pjp-holdings.csv",
 "json_book": "https://etfiq.com/data/books/pjp.json",
 "markdown": "https://etfiq.com/funds/pjp/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of PJP, data as of Oct 13, 2026. https://etfiq.com/funds/pjp/holdings/"
}